Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Human Liver Models Market Size, Share and Growth Outlook, 2026: Analysis By Product & Technology (2D Models , 3D Cell Cultures , Liver-on-a-Chip , 3D Bioprinted Liver Constructs), By Application (ADME , Toxicology & Hepatotoxicity Testing, Disease Modeling, Drug Discovery & Target Validation), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Human Liver Models Market size is forecast to increase from $1.58 Billion in 2026 to $4.17 Billion in 2034 at a CAGR of 12.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007707
Pages: 211 Pages

Human Insulin Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Traditional , Insulin Analogues , Biosimilar Human Insulin, Premixed Insulin Combinations), By Device (Insulin Pens , Syringes & Vials, Insulin Pumps & Infusion Systems), By Application (Type 1 Diabetes, Type 2 Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drugstores, Online) Companies, and Country Forecast, 2021 to 2034

Global Human Insulin Market size is forecast to increase from $57.03 Billion in 2026 to $86.2 Billion in 2034 at a CAGR of 5.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007706
Pages: 230 Pages

Human Insulin Drugs and Delivery Devices Market Size, Share and Growth Outlook, 2026: Analysis By Drug Type (Basal or Long-Acting Insulins, Bolus or Fast-Acting Insulins, Traditional Human Insulins, Combination Insulins, Biosimilar Insulins), By Delivery Device (Insulin Pens, Insulin Pumps, Insulin Syringes, Insulin Jet Injectors), By Application (Type 1 Diabetes, Type 2 Diabetes), By End User (Hospitals, Clinics, Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Human Insulin Drugs and Delivery Devices Market size is forecast to increase from $35.75 Billion in 2026 to $70.2 Billion in 2034 at a CAGR of 8.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007705
Pages: 215 Pages

Human Immunoglobulin Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Intravenous Immunoglobulin , Subcutaneous Immunoglobulin ), By Form (Liquid, Lyophilized), By Application (Primary Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy , Immune Thrombocytopenic Purpura , Guillain-Barré Syndrome, Multifocal Motor Neuropathy, Myasthenia Gravis), By End User (Hospitals, Clinics, Home Care) Companies, and Country Forecast, 2021 to 2034

Global Human Immunoglobulin Market size is forecast to increase from $19.15 Billion in 2026 to $41.65 Billion in 2034 at a CAGR of 10.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007704
Pages: 227 Pages

Human Identification Market Size, Share and Growth Outlook, 2026: Analysis By Product & Service (Assay Kits, Reagents, & Consumables, Analytical Instruments & Hardware, Software & Data Analytics Services), By Technology (Polymerase Chain Reaction , Next-Generation Sequencing , Capillary Electrophoresis, Nucleic Acid Extraction & Purification), By Application (Forensic Applications & Criminal Investigations, Paternity & Kinship Testing, Disaster Victim Identification , Anthropology & Population Genetics), By End-User (Forensic & Crime Laboratories, Government Agencies & Law Enforcement, Academic & Research Institutions, Diagnostic & Private Testing Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Human Identification Market size is forecast to increase from $1.21 Billion in 2026 to $2.71 Billion in 2034 at a CAGR of 10.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007703
Pages: 217 Pages

Human Growth Hormone Market Size, Share and Growth Outlook, 2026: Analysis By Application (Growth Hormone Deficiency , Turner Syndrome, Idiopathic Short Stature , Prader-Willi Syndrome , Small for Gestational Age , Chronic Renal Insufficiency), By Formulation Type (Short-Acting , Long-Acting ), By Route of Administration (Subcutaneous, Intravenous, Intramuscular), By Patient Type (Pediatric Population, Adult Population), By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Human Growth Hormone Market size is forecast to increase from $8.57 Billion in 2026 to $16.58 Billion in 2034 at a CAGR of 8.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007702
Pages: 212 Pages

Human Embryonic Stem Cells Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (hESC Lines, Culture Media & Reagents, Instruments & Consumables), By Application (Regenerative Medicine, Stem-Cell Biology Research, Tissue Engineering, Toxicology & Drug Testing), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Clinical Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Human Embryonic Stem Cells Market size is forecast to increase from $2.99 Billion in 2026 to $6.84 Billion in 2034 at a CAGR of 10.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007701
Pages: 226 Pages

Human Combination Vaccines Market Size, Share and Growth Outlook, 2026: Analysis By Combination Type (DTaP, DTaP, MMR II, Hep B-Hib, Others), By Product Type (Inactivated Vaccine, Live Attenuated Vaccine), By Age Group (Children, Adults), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Human Combination Vaccines Market size is forecast to increase from $17.21 Billion in 2026 to $32.81 Billion in 2034 at a CAGR of 8.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007700
Pages: 210 Pages

Human Chorionic Gonadotropin (HCG) Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Urinary-Derived HCG, Recombinant HCG), By Therapeutic Application (Female Infertility Treatment, Male Hypogonadism, Oligospermic Treatment, Cryptorchidism Treatment, Chronic Pain), By End User (IVF Clinics, Hospitals, Diagnostic Laboratories, Research Institutions, Home-Care Settings) Companies, and Country Forecast, 2021 to 2034

Global Human Chorionic Gonadotropin (HCG) Market size is forecast to increase from $1.25 Billion in 2026 to $2.02 Billion in 2034 at a CAGR of 6.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007699
Pages: 230 Pages

HSV Testing Market Size, Share and Growth Outlook, 2026: Analysis By Test Type (Molecular Tests , Serological Tests , Direct Detection or Culture Tests, Rapid Antigen Tests), By Virus Type (HSV-1 Testing, HSV-2 Testing, HSV Type-Unspecified), By Sample Type (Blood, Vesicular Swab, Ulcer, Cerebrospinal Fluid ), By End User (Hospitals, Clinical Diagnostic Laboratories, Point-of-Care Settings, Home Care Settings, Blood Banks and Plasma Collection Centers) Companies, and Country Forecast, 2021 to 2034

Global HSV Testing Market size is forecast to increase from $788.64 Million in 2026 to $1285.72 Million in 2034 at a CAGR of 6.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007698
Pages: 223 Pages